Letter to the Editor on the "Effects of Microbiota-driven Therapy on Circulating Indoxyl Sulfate and p-Cresyl Sulfate in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials"
- PMID: 37270212
- PMCID: PMC8970842
- DOI: 10.1093/advances/nmac010
Letter to the Editor on the "Effects of Microbiota-driven Therapy on Circulating Indoxyl Sulfate and p-Cresyl Sulfate in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials"
Comment on
-
Effects of Microbiota-Driven Therapy on Circulating Indoxyl Sulfate and P-Cresyl Sulfate in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Adv Nutr. 2022 Aug 1;13(4):1267-1278. doi: 10.1093/advances/nmab149. Adv Nutr. 2022. PMID: 34905018 Free PMC article.
Similar articles
-
Effects of Microbiota-Driven Therapy on Circulating Indoxyl Sulfate and P-Cresyl Sulfate in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Adv Nutr. 2022 Aug 1;13(4):1267-1278. doi: 10.1093/advances/nmab149. Adv Nutr. 2022. PMID: 34905018 Free PMC article.
-
Protein-bound uremic toxin lowering strategies in chronic kidney disease: a systematic review and meta-analysis.J Nephrol. 2021 Dec;34(6):1805-1817. doi: 10.1007/s40620-020-00955-2. Epub 2021 Jan 23. J Nephrol. 2021. PMID: 33484425
-
Diet Quality and Protein-Bound Uraemic Toxins: Investigation of Novel Risk Factors and the Role of Microbiome in Chronic Kidney Disease.J Ren Nutr. 2022 Sep;32(5):542-551. doi: 10.1053/j.jrn.2021.10.003. Epub 2021 Nov 12. J Ren Nutr. 2022. PMID: 34776340 Clinical Trial.
-
Possible Effects of Uremic Toxins p-Cresol, Indoxyl Sulfate, p-Cresyl Sulfate on the Development and Progression of Colon Cancer in Patients with Chronic Renal Failure.Genes (Basel). 2023 Jun 13;14(6):1257. doi: 10.3390/genes14061257. Genes (Basel). 2023. PMID: 37372437 Free PMC article. Review.
-
The impact of dietary nutrient intake on gut microbiota in the progression and complications of chronic kidney disease.Kidney Int. 2022 Oct;102(4):728-739. doi: 10.1016/j.kint.2022.06.025. Epub 2022 Jul 20. Kidney Int. 2022. PMID: 35870642 Review.
References
-
- Chen L, Shi J, Ma X, Shi D, Qu H. Effects of microbiota-driven therapy on circulating indoxyl sulfate and p-cresyl sulfate in patients with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials. Adv Nutr. 2021 Dec 14:nmab149. Online ahead of print. doi: 10.1093/advances/nmab149. - PMC - PubMed
-
- Biruete A, Cross TWL, Allen JM, Kistler BM, de Loor H, Evenepoel P, Fahey GC, Bauer L, Swanson KS, Wilund KR. Effect of dietary inulin supplementation on the gut microbiota composition and derived metabolites of individuals undergoing hemodialysis: a pilot study. J Ren Nutr. 2021;31(5):512–22. - PMC - PubMed
-
- Borges NA, Carmo FL, Stockler-Pinto MB, de Brito JS, Dolenga CJ, Ferreira DC, Nakao LS, Rosado A, Fouque D, Mafra D. Probiotic supplementation in chronic kidney disease: a double-blind, randomized, placebo-controlled trial. J Ren Nutr. 2018;28(1):28–36. - PubMed
-
- Deeks JJ, Higgins JP, Altman DG. Analysing data and undertaking meta-analyses. In: Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page M, Welch V, editors. Cochrane Handbook for Systematic Reviews of Interventions. 2nd edition. Chichester (UK): John Wiley & Sons; 2019. p. 241–84.